| 2025-12-05 | Kerr Douglas | Chief Medical Officer | Sell | 880 | $20.72 | $18,233.60 | -1.0% | → |
| 2025-12-05 | Cox John | CEO & President | Sell | 2,662 | $20.72 | $55,156.64 | -1.3% | → |
| 2025-12-05 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | 144 | $20.72 | $2,983.68 | -0.2% | → |
| 2025-09-05 | Cox John | CEO & President | Sell | 2,640 | $13.41 | $35,402.40 | -1.3% | → |
| 2025-09-05 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | 1,038 | $13.29 | $13,794.42 | -0.5% | → |
| 2025-09-05 | Kerr Douglas | Chief Medical Officer | Sell | 4,425 | $13.30 | $58,841.97 | -2.4% | → |
| 2025-07-14 | Cox John | CEO & President | Buy | 100,000 | $9.11 | $911,000.00 | +70.3% | → |
| 2025-06-05 | Cox John | CEO & President | Sell | 4,060 | $13.35 | $54,201.00 | -2.8% | → |
| 2025-06-05 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | 146 | $13.35 | $1,949.10 | -0.2% | → |
| 2025-06-05 | Kerr Douglas | Chief Medical Officer | Sell | 1,342 | $13.35 | $17,915.70 | -1.4% | → |
| 2025-03-13 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | 143 | $12.12 | $1,733.16 | -0.1% | → |
| 2025-03-11 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 2,153 | $11.38 | $24,501.14 | -1.1% | → |
| 2025-03-11 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | 1,343 | $11.38 | $15,283.34 | -1.1% | → |
| 2025-03-05 | Kerr Douglas | Chief Medical Officer | Sell | 1,343 | $11.83 | $15,887.69 | -1.4% | → |
| 2025-03-05 | Cox John | CEO & President | Sell | 4,061 | $11.83 | $48,041.63 | -2.7% | → |
| 2025-03-05 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,094 | $11.83 | $12,942.02 | -0.5% | → |
| 2025-03-05 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | 917 | $11.83 | $10,848.11 | -0.7% | → |
| 2025-02-18 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | 2,488 | $13.95 | $34,707.60 | -2.0% | → |
| 2025-02-18 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 2,598 | $13.95 | $36,242.10 | -1.3% | → |
| 2024-12-11 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 2,334 | $28.12 | $65,632.08 | -1.1% | → |
| 2024-12-11 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | 1,455 | $28.12 | $40,914.60 | -1.1% | → |
| 2024-12-09 | Kersten Dirk | - | Sell | 136,112 | $29.30 | $3,988,016.16 | -1.2% | → |
| 2024-12-05 | Kersten Dirk | - | Sell | 138,845 | $29.38 | $4,079,360.51 | -1.2% | → |
| 2024-12-03 | Kersten Dirk | - | Sell | 110,933 | $29.50 | $3,273,008.14 | -0.6% | → |
| 2024-11-18 | Incerti Carlo | - | Sale+OE | 16,500 | $28.73 | $474,045.00 | -100% | → |
| 2024-11-18 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 2,856 | $28.20 | $80,539.20 | -2.0% | → |
| 2024-11-18 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | 2,735 | $28.20 | $77,127.00 | -2.8% | → |
| 2024-11-14 | Rhodes Jason P | - | Sell | 782 | $33.10 | $25,884.20 | - | → |
| 2024-11-14 | Kersten Dirk | - | Sell | 19,732 | $34.14 | $673,747.50 | -0.3% | → |
| 2024-10-21 | Kersten Dirk | - | Sell | 13,535 | $35.16 | $475,878.50 | -8.5% | → |
| 2024-10-17 | Kersten Dirk | - | Sell | 36,684 | $35.29 | $1,294,437.06 | -16.5% | → |
| 2024-10-03 | Kersten Dirk | - | Sell | 5,441 | $35.13 | $191,142.33 | -4.2% | → |
| 2024-10-02 | Kersten Dirk | - | Sell | 29,941 | $35.32 | $1,057,459.52 | -9.7% | → |
| 2024-09-30 | Kersten Dirk | - | Sell | 30,974 | $35.50 | $1,099,696.99 | -5.7% | → |
| 2024-09-26 | Kersten Dirk | - | Sell | 1,260 | $35.29 | $44,465.40 | -0.7% | → |